2020 R&D Tax Refund
Filed with ASX · · 1 page · English
® MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce that it has received its 2020 R&D tax incentive claim of $2,612,159 from the Australian Taxation Office. This is higher than the $2,197,028 received in respect of the 2019 claim and reflects increased R&D spend in 2020 as the Company under
Imagion Biosystems Ltd. on 6ix
Story so far
Earlier from Imagion Biosystems
- First-in-human study update - First patient enrolled
- Appendix 4C - quarterly
- IBX raises $6M in placement
- Appendix 4C & Quarterly Activity Report
- Imagion announces HREC approval for Phase I study
Later from Imagion Biosystems
- Half-year results release
- Full Year Results Release
- First-in-human Study Progress Update
- Prostate cancer research update
- 2021 R&D Tax Refund
Follow Imagion Biosystems into a list and get an email when it puts out news.
Follow Imagion Biosystems